✦ LIBER ✦

A limited-sampling model for the pharmacokinetics of carboplatin administered in combination with paclitaxel

✍ Scribed by Vinodh R. Nannan Panday; Laurence J. C. van Warmerdam; Manon T. Huizing; Wim W. Ten Bokkel Huinink; Jan H. M. Schellens; Jos H. Beijnen

Publisher: Springer-Verlag
Year: 1999
Tongue: English
Weight: 115 KB
Volume: 125
Category: Article
ISSN: 1432-1335
DOI: 10.1007/s004320050324

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Population pharmacokinetic and limited s

Population pharmacokinetic and limited sampling models for carboplatin administered in high-dose combination regimens with peripheral blood stem cell support

✍ Meiyu Shen; Russell J. Schilder; Coleman Obasaju; James M. Gallo 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 141 KB

A limited sampling model for the pharmac

A limited sampling model for the pharmacokinetics of etoposide given orally

✍ Donatella Gentili; Massimo Zucchetti; Valter Torri; Cristiana Sessa; Jolanda Jon 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 523 KB

Pharmacokinetics of carboplatin administ

Pharmacokinetics of carboplatin administered in combination with the bradykinin agonist Cereport (RMP-7) for the treatment of brain tumours

✍ Huw D. Thomas; Michael J. Lind; Judith Ford; Norman Bleehen; A. Hilary Calvert; 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 104 KB

Comparison of outcomes for elderly patie

Comparison of outcomes for elderly patients treated with weekly paclitaxel in combination with carboplatin versus the standard 3-weekly paclitaxel and carboplatin for advanced nonsmall cell lung cancer

✍ Suresh Ramalingam; Michael C. Perry; Renato V. La Rocca; David Rinaldi; Preston 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

A limited-sampling method for evaluation

A limited-sampling method for evaluation of the area under the curve of ultrafilterable carboplatin in children

✍ F. Doz; S. Urien; E. Chatelut; J. Michon; H. Rubie; J. M. Zucker; P. Canal; G. B 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 274 KB

A Phase I report of paclitaxel dose esca

A Phase I report of paclitaxel dose escalation combined with a fixed dose of carboplatin in the treatment of head and neck carcinoma

✍ Frank R. Dunphy; James H. Boyd; Han J. Kim; Cherie H. Dunphy; Bruce R. Harrison; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 2 views

Thirty-six patients with untreated Stage III/IV head and neck carcinoma were treated and were evaluable for toxicity. All patients had lesions that were